{"efta_number": "EFTA00747181", "page_count": 5, "url": "https://epstein-data.com/EFTA00747181", "pdf_url": "https://epstein-data.com/pdf/EFTA00747181.pdf", "pages": [{"efta_number": "EFTA00747181", "page_number": 0, "text_content": "From: Jeffrey Epstein <jeevacationggmail.com> \nTo: David Stern\nSubject: Re: Offer letter \nDate: Tue, 23 Mar 2010 11:12:57 +0000 \n> \nthe basis of our initial analysis we value the Business at approximately US$50m. This value assumes \nthe making of our investment in full, reflects the expected synergies of our proposed partnership, your \nprojections being fulfilled and significant future opportunities that we believe lie ahead in this joint \nventure. \nI confirm that our offer is as follows: \n1. $3m for the purchase of 50.1% of the entire share capital (issued or under option) of China \nMedical Data Services Limited or of its wholly owned subsidiary Asia Gateway Limited \n(the Acquisition Vehicle and its business, the Business); and \n2. The advancement of up to $16m of working capital into the Acquisition Vehicle as follows: \n2.1 this will probably be by way of nonvoting preference shares or loans at a market \ncoupon but this would be at a discount to the level that a private equity house would offer; \n2.2 $8m will be advanced at the outset; \n2.3 the next $8m will be advanced in quarterly instalments during 2011 subject to the \nfulfilment of the 2011 milestones indicated in blue in Appendix 1 to this letter. \nThe acquisition of the 50.1% stake and the initial working capital advance of $8m will both be \nconditional upon execution of both the contract with central MOHRSS on national standards and the \nresearch service contract with central MOHRSS in a form and content approved by us (reflecting the \nanticipated form of those contracts); \nWe continue to work on the exact structure but any change would reflect the same economic effect of \nthese terms. \nThis offer is subject to the following conditions: \n1. satisfactory completion of confirmatory due diligence; and \n2. agreement between us and you on the terms of the acquisition agreement, investment \nagreement, consultancy terms for you and other associated matters that need to be documented \nin relation to a transaction of this type. Inevitably there will be some complexity in relation to \nthese documents but we will be as straightforward as we can. The initial matters which we have \nconsidered with you are: \ni. of the 49.9% which we will not hold in the Acquisition Vehicle, you will transfer or grant \noptions over up to 10% to existing management. (We should like to discuss with you the \nform of transfer of shares / grant of options to ensure that the existing management team \nEFTA00747181\n", "char_count": 2479}, {"efta_number": "EFTA00747181", "page_number": 1, "text_content": "are fully tied in, in order to grow the Business in the medium term.) New management team \nmembers would be rewarded by profit share and bonus arrangements in accordance with \nan agreed budget \nii. we wish to put in place a structure whereby the ownership of non-data or publishing assets \n(such as a pure IT or software business) (Non-Core Business) be held such that our \nshareholding is restricted to 40% \niii. in relation to the Non-Core Business, you would have board control and a casting vote as \nto divestment decisions; conversely we would have board control and a casting vote on \nthose issues in relation to the Acquisition Vehicle. Similarly, for the Non-Core Business you \nwould have drag rights in respect of our shares on a sale (and we would have tag rights); \nthe opposite would apply in relation to the Acquisition Vehicle. \niv. we both envisage your ongoing role as being Chairman. For an initial period of 2 years this \nwould involve a considerable time commitment from you and would include the following \nresponsibilities: \na. supervision and control of the Beijing based management team; \nb. the supervision and interaction, integration and communication with the \nAGC business and its strategic partner Informa; \nc. AGC corporate governance and related issues; \nd. working with its Informa on China related guidance and protocol issues in direct \nconnection with the AGC business; \ne. overall oversight and responsibility for supervision of the Beijing based management \nteam in order to successfully implement the [Business Plan] and the achievement of \nthe revenue and profit targets set out in that plan. \nAfter the initial 2 year period, your role may be reduced to supervision and control as is \ndeemed necessary for the continuous growth of the business as well as the \ninteraction required should any unforeseen issues arise that may pose threats to the \nsuccessful operation of the business. \nv. if in the future you wish to dispose of any of your shares then we would have an option to \nbuy them. and you would have the right to buy ours We have discussed a third party \nvaluation mechanism - we would then have a window to buy once the value is determined. \nIf we do not exercise that option you will then have a further window to sell to a third party \nbut if you propose to do so at a lower value then we will have an opportunity to exercise \nour option at that lower valuation level. Conversely we could elect to sell alongside you to \nthat third party \nvi. we envisage each of us having joint consent rights reflecting the partnership nature of the \nproposed arrangements, along the lines of those set out in the Appendix, but subject to (iii) \nabove \nvii. if your projections are not achieved or more cash investment is required, we need to agree \nmechanisms for further investment, dilution, sale, winding up or other remedies. If the \nshortfall is material then we will have the right to make these decisions. \nBy counter-signing and returning to us the enclosed copy of this letter, you undertake: \na. to procure that the arrangements contemplated in this letter remain confidential (and you \nacknowledge that this letter may constitute price sensitive information in relation to the \nInforma group as the shares of the ultimate parent company are quoted on the London \nStock Exchange); and \nb. (in consideration of us incurring costs in relation to investigations and due diligence) not to \ninitiate, continue, participate in or otherwise facilitate any discussions or arrangements for \nor anticipating the disposal (or any other arrangement concerning ownership, control or \nencumbrance) of any part of the Business to any entity other than us or otherwise to make \nEFTA00747182\n", "char_count": 3723}, {"efta_number": "EFTA00747181", "page_number": 2, "text_content": "available any confidential information concerning either Acquisition Vehicle or the Business \nto anyone else from today's date to Friday 7th May 2010. \nc. (and we undertake to you) to work together in good faith in order to satisfy the conditions \nabove as soon as reasonably practicable and with a clear objective of on or prior to \n30th April 2010. \nEach party shall be responsible for its respective costs and expenses in relation to this transaction. \nInforma will produce drafts of the principal documents and will be responsible for obtaining tax advice \nin relation to its investment. \nThis letter is legally binding on both you and us. It is subject to English law and you and we agree to \nthe exclusive jurisdiction of the Courts of England. \nAs you know we are incredibly excited by this and think that we can make fantastic partners. If you \nare in agreement with this letter please counter-sign and return a copy of this letter. \nYours sincerely \nLindsey Roberts \nFor and on behalf of Informa UK Limited \nAgreed \nDate: \nDavid Stern \nAppendix \n• Amendment to the Articles of Association and Memorandum of Association; \n• Change in nature of business (including entry into any new business); \n• Material litigation matters; \n• The entry into, amendment or termination of any material contract; \n• The borrowing or lending of any material loan or advance, any guarantee, indemnity or surety \ncontract, inter-corporate loans and investments or guarantees/security, whether made to or by or \non behalf of the Company/ subsidiary; \n• Merger, demerger, restructuring (including the incorporation of any subsidiary or consolidation or \nacquisition of a stake) in another company; \n• Material tax planning / structuring that is, or should be, placed before the Board; \n• Winding up, liquidation or dissolution; \n• Acquisition of all or substantially all of the properties, assets or stock of any other company or \nentity; \n• Issuance of shares or warrants or any other rights to shares or sweat equity, or grant of options \nfor such shares to any person or entity; \n• Creation or issuance of new classes of shares \n• Sale, lease, transfer, exclusive license or other disposition of all or a material portion of the \nproperties, assets, stock or business of the Company; \n• All actions and decisions pertaining to a liquidity event (i.e. any initial public offering, trade sale, \nor other possible way to provide an exit of its Investment), including without limitation \nEFTA00747183\n", "char_count": 2486}, {"efta_number": "EFTA00747181", "page_number": 3, "text_content": "appointment of the investment banking firms and other advisers in relation thereto; \n• Any change in the accounting year or accounting methods and appointment or change in the \ninternal or external auditors; \n• Dividend policy, declaring dividends and redeeming or buying back shares; \n• Change in capital structure/ownership, including incurring any debt, other than working capital or \nother debt in the ordinary course of business in accordance with the approved business plan or \nshort term debt; \n• Any transaction that would result in a change in control of the Company or any subsidiary; and \n• Providing any rights to a shareholder (other than rights that he would in any event be entitled to \nunder law). \n• Annual Budget and Business Plan \n• Employment terms of key staff \n• Release of restrictive covenants of employees or third parties \n• Licensing of intellectual property rights. \nOn Tue, Mar 23, 2010 at 7:03 AM, David Stem cj \n-- wrote: \nTHANK YOU !! \nBegin forwarded message: \nFrom: \"Jacobs, Rachel\" <I \nDate: 19 March 2010 12:46:40 GMT \nTo: < \nCc: \"Roberts, Lindse \n> \nSubject: Offer letter \nDavid \nI attach a redraft of the offer for your consideration. \n> \n>, \"Burton, John\" \nI have added the wording in relation to tax advice etc. In relation to the market coupon on the $16m, we have \nindicated that this will be at a discount at the rate that would be offered by a private equity house but it is \ndifficult at this stage to specify what that will be. Lets discuss on our call at 2.00 pm today. \nBest \nRachel \nRachel Jacobs \nGeneral Counsel UK \nInforma Group plc, Mortimer House, 37-41 Mortimer Street, London W1T 3JH \nTel: 4-44 (0)20 7017 4345 \nFax: +44 (0)20 7017 4286 \nMobile: \nemail: \nwebsite: www.informa.com \nRegistered in England under number 3099067 \nThe information contained in this email message may be confidential. If you are not the intended \nrecipient, any use, interference with, disclosure or copying of this material is unauthorised and \nprohibited. Although this message and any attachments are believed to be free of viruses, no \nresponsibility is accepted by Informa for any loss or damage arising in any way from receipt or use \nEFTA00747184\n", "char_count": 2186}, {"efta_number": "EFTA00747181", "page_number": 4, "text_content": "thereof. Messages to and from the company are monitored for operational reasons and in \naccordance with lawful business practices. \nIf you have received this message in error, please notify us by return and delete the message and \nany attachments. Further enquiries/returns can be sent to postmaster@informa.com \nThis message is confidential. It may also be privileged or otherwise \nprotected by work product immunity or other legal rules. \nIf you have received it by mistake please let us know by reply and then \ndelete it from your system; \nyou should not copy the message or disclose its contents to anyone. \nOpinions, conclusions and other information in this message that do not \nrelate to the official business of Asia Gateway Ltd. \nshall be understood as neither given nor endorsed by it. \nAsia Gateway Ltd. \nMichelin House \n81 Fulham Road \nLondon SW3 6RD \nUK \nTel: +44 (0)20 7838 6788 \nFax: +44 (0)20 7838 6888 \nThe information contained in this communication is \nconfidential, may be attorney-client privileged, may \nconstitute inside information, and is intended only for \nthe use of the addressee. It is the property of \nJeffrey Epstein \nUnauthorized use, disclosure or copying of this \ncommunication or any part thereof is strictly prohibited \nand may be unlawful. If you have received this \ncommunication in error, please notify us immediately by \nreturn e-mail or by e-mail to jeevacation@gmail.com, and \ndestroy this communication and all copies thereof, \nincluding all attachments. \nEFTA00747185\n", "char_count": 1512}]}